LABOCANNA S.A. ZY-10 Market Cap ($788.53K)
Market Cap & Net Worth: LABOCANNA S.A. ZY-10 (9Y2)
LABOCANNA S.A. ZY-10 market cap. LABOCANNA S.A. ZY-10 (F:9Y2) has a market capitalization of $788.53K (€674.48K) as of November 4, 2026. Listed on the F stock exchange, this Germany-based company holds position #30810 globally and #2696 in its home market, demonstrating a -3.45% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying LABOCANNA S.A. ZY-10's stock price €0.04 by its total outstanding shares 21197160 (21.20 Million). Also see LABOCANNA S.A. ZY-10 (9Y2) cash flow conversion for how efficiently the company converts equity into cash flow.
LABOCANNA S.A. ZY-10 Market Cap History (2021–2026)
LABOCANNA S.A. ZY-10 market cap history from 2021 to 2026. Data shows change from $7.78 Million to $971.44K (-37.60% CAGR). Check LABOCANNA S.A. ZY-10 (9Y2) share price today for real-time trading data and today's change.
LABOCANNA S.A. ZY-10 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how LABOCANNA S.A. ZY-10's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 9Y2 year-over-year net asset growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.39x
LABOCANNA S.A. ZY-10's market cap is 0.39 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $2.30 Million | $2.93K | -$1.19 Million | 785.93x | N/A |
| 2023 | $1.84 Million | $16.52K | -$598.72K | 111.31x | N/A |
| 2024 | $1.34 Million | $1.01 Million | -$442.21K | 1.33x | N/A |
| 2025 | $867.36K | $2.24 Million | -$872.55K | 0.39x | N/A |
Competitor Companies of 9Y2 by Market Capitalization
Companies near LABOCANNA S.A. ZY-10 in the global market cap rankings as of November 4, 2026. Also see total assets of LABOCANNA S.A. ZY-10 for a full breakdown of the balance sheet.
Key companies related to LABOCANNA S.A. ZY-10 by market ranking:
- Cintas Corporation (NASDAQ:CTAS): Ranked #341 globally with a market cap of $80.31 Billion USD.
- Thomson Reuters Corp (TO:TRI): Ranked #506 globally with a market cap of $53.40 Billion USD ( CA$73.83 Billion CAD).
- Copart Inc (NASDAQ:CPRT): Ranked #866 globally with a market cap of $30.76 Billion USD.
- Global Payments Inc (NYSE:GPN): Ranked #1132 globally with a market cap of $22.79 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #341 | Cintas Corporation | NASDAQ:CTAS | $80.31 Billion | $224.77 |
| #506 | Thomson Reuters Corp | TO:TRI | $53.40 Billion | CA$170.41 |
| #866 | Copart Inc | NASDAQ:CPRT | $30.76 Billion | $31.93 |
| #1132 | Global Payments Inc | NYSE:GPN | $22.79 Billion | $99.63 |
Market Capitalization of LABOCANNA S.A. ZY-10 (2021–2026)
Market capitalization of LABOCANNA S.A. ZY-10 from 2021 to today. Between 2021 and today, LABOCANNA S.A. ZY-10's market cap moved from $7.78 Million to $ 971.44K, with a yearly change of -37.60%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €971.44K | +12.00% |
| 2025 | €867.36K | -35.42% |
| 2024 | €1.34 Million | -26.95% |
| 2023 | €1.84 Million | -20.22% |
| 2022 | €2.30 Million | -70.38% |
| 2021 | €7.78 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of LABOCANNA S.A. ZY-10 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $788.53K USD |
| MoneyControl | $788.53K USD |
| MarketWatch | $788.53K USD |
| marketcap.company | $788.53K USD |
| Reuters | $788.53K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About LABOCANNA S.A. ZY-10
Labocanna S.A. engages in the cultivation, production, and distribution of hemp product. The company also offers food and medical hemp-derived products, as well as CBD oil under the Labocanna brand name. It is also involved in commercial real estate management activities. Its products are used in cosmetics, plastics, and textiles. The company was formerly known as Foxbuy.com S.A. and changed its … Read more